These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5900652)

  • 1. Ovulation inhibition with a log-acting injectable. II. The cycling effects of varying progestagen-estrogen combinations.
    Rizkallah TH; Taymor ML
    Am J Obstet Gynecol; 1966 Jan; 94(2):161-4. PubMed ID: 5900652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
    Zaki K; Younis N; Nour H
    Egypt Popul Fam Plann Rev; 1971 Dec; 4(2):1-5. PubMed ID: 12255961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, double-blind, comparative clinical study on the efficacy and acceptability of a monthly injectable contraceptive combination of 150 mg dihydroxyprogesterone acetophenide and 10 mg estradiol enanthate compared to a monthly injectable contraceptive combination of 90 mg dihydroxyprogesterone acetophenide and 6 mg estradiol enanthate.
    Coutinho EM; Spinola P; Barbosa I; Gatto M; Tomaz G; Morais K; Yazlle ME; de Souza RN; Pinho Neto JS; Leal Wde B; Leal C; Hippolito SB; Abranches AD
    Contraception; 1997 Mar; 55(3):175-81. PubMed ID: 9115007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual regulation by sequential hormone therapy.
    Beaton JH
    West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation inhibition with sequential therapy. A continuing clinical study of fertility control.
    Suran RR
    Fertil Steril; 1967; 18(5):598-615. PubMed ID: 6037449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial menstrual cycles induced in ovulating women by monthly injection of progestogen-estrogen.
    Reifenstein EC; Pratt TE; Hartzell KA; Shafer WB
    Fertil Steril; 1965; 16(5):652-62. PubMed ID: 5833973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive.
    Recio R; Garza-Flores J; Schiavon R; Reyes A; Diaz-Sanchez V; Valles V; Luz de la Cruz D; Oropeza G; Perez-Palacios G
    Contraception; 1986 Jun; 33(6):579-89. PubMed ID: 3769482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of fertility by monthyl injections of a mixture of norgestrel and a long-acting estrogen. A preliminary report.
    de Souza JC; Coutinho EM
    Contraception; 1972 May; 5(5):395-9. PubMed ID: 4650657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Existing once-a-month combined injectable contraceptives.
    Toppozada MK
    Contraception; 1994 Apr; 49(4):293-301. PubMed ID: 8013216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical mucus in estrous ewes after treatment with estrogen, progestogens and intrauterine devices.
    Rexroad CE; Barb CR
    J Anim Sci; 1977 Jan; 44(1):102-5. PubMed ID: 64467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical impression of a combination-type contraceptive: Neo-Lyndiol.
    Gede CE
    J Int Med Res; 1975; 3(4):284-91. PubMed ID: 1165003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.